Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) stated cash, cash equivalents and marketable securities value of $64.7M
On Thursday Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) listed below -1.9% and ended at $7.76. The stock exchange capitalization came
Read more